Key result
HyperVigilance platform reduces mean BP by ~9 mmHg vs standard medical care.
Why the study?
Electronic health solutions for chronic diseases like hypertension have generated interest, but further in-depth, evidence-based evaluation of their effectiveness is required.
Does the 'HyperVigilance' web platform improve blood pressure control in hypertensive patients?
Does the 'HyperVigilance' web platform improve blood pressure control in hypertensive patients?
Absolute Event Rate: 130.75% vs 139.75%
p-value: p=0.001
The use of a personal electronic health assistant platform significantly improved blood pressure control, enhanced quality of life, and reduced treatment-associated costs in hypertensive patients.
Supports digital platform use in hypertension care; extends RCT evidence for e-health tools improving BP control.
Introduction: Chronic diseases pose significant challenges in healthcare, which has driven the development of electronic health solutions. The effectiveness of these solutions in the management of diseases such as hypertension has generated interest, but further in-depth, evidence-based evaluation is required.Objective: The study aims to comprehensively evaluate how a customizable web platform, called "HyperVigilance", influences blood pressure control in hypertensive patients, considering additional variables such as patient satisfaction, quality of life and costs associated with treatment. In addition, the aim is to explore possible demographic factors that could moderate the results.Methodology: The study was conducted with a quasi-experimental research design that included an intervention group using the "HyperVigilance" platform and a control group receiving standard medical care. Statistical tests were applied and demographic factors such as age, gender and socioeconomic status were considered.Results: The use of the "HyperVigilance" platform resulted in a significant reduction in blood pressure, increased patient satisfaction and a marked improvement in quality of life, as well as a reduction in the costs associated with the treatment of hypertension.Conclusions: The study concludes that the "HyperVigilance" platform is effective in controlling blood pressure and improving quality of life in patients with hypertension. The results support the growing role of digital interventions in chronic disease management, but highlight the need for long-term studies and exploration of different populations for a more complete understanding of their impact.
No takes yet. Share an insight, caveat, or question.
Cruz et al. (2023) studied Hypertension (n=100). HyperVigilance platform vs. Standard medical care was evaluated on Post-intervention blood pressure (mmHg) (p=0.001). The HyperVigilance platform significantly reduced mean post-intervention blood pressure to 130.75 mmHg compared to 139.75 mmHg with standard medical care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: